オクラホマにおける高血圧の臨床試験
オクラホマ内の拠点で、高血圧に関する9件の研究が参加者を募集しています。
オクラホマ内の都市
公式研究テキスト（英語）
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- CRO Call Center, Tulsa
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07142356BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- South Oklahoma Heart Research, Oklahoma City
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT06059638A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
被験者募集中
18歳〜85歳 · 全性別 · 2026/10/01更新 · NCT07214376EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Central States Research, Tulsa
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Ascension St. John Clinical Research Institute, Bartlesville
被験者募集中
22歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Conrad Clinical Research, Edmond
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Norman
- Vanda Investigative Site, Oklahoma City
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT07090161ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。